Kiniksa Pharmaceuticals International Plc (KNSA): Next-Year EPS Estimate 39.55%
As of 2026-06-04, Kiniksa Pharmaceuticals International Plc (KNSA) has a next-year EPS growth estimate of 39.55%.
On 2026-06-04, analyst consensus for KNSA's next-year EPS growth shifted from 38.00% to 39.55% — a positive change of 1.55 percentage points. Current-year growth is projected at 82.96%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 39.55%
- EPS growth this year
- 82.96%
- EPS next quarter (est)
- $0.31
- Last price
- $49.23
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 39.55% | 82.96% | $0.31 | $49.23 |
| 2026-06-03 | 38.00% | 82.96% | $0.30 | $47.85 |
| 2026-06-02 | 38.00% | 82.96% | $0.30 | $46.92 |
| 2026-06-01 | 38.00% | 82.96% | $0.30 | $48.43 |
| 2026-05-31 | 38.00% | 82.96% | $0.30 | $48.38 |
| 2026-05-28 | 38.00% | 82.96% | $0.30 | $50.84 |
| 2026-05-27 | 38.00% | 82.96% | $0.30 | $51.84 |
| 2026-05-26 | 38.00% | 82.96% | $0.30 | $52.86 |
| 2026-05-25 | 38.00% | 82.96% | $0.30 | $53.24 |
| 2026-05-24 | 38.00% | 82.96% | $0.30 | $53.24 |
| 2026-05-21 | 38.00% | 82.96% | $0.30 | $53.65 |
| 2026-05-20 | 38.00% | 82.96% | $0.30 | $54.28 |
| 2026-05-19 | 38.00% | 82.96% | $0.30 | $53.34 |
| 2026-05-18 | 38.00% | 82.96% | $0.30 | $53.64 |
| 2026-05-17 | 38.00% | 82.96% | $0.30 | $56.51 |
| 2026-05-14 | 38.00% | 82.96% | $0.30 | $58.54 |
| 2026-05-13 | 38.00% | 82.96% | $0.30 | $59.54 |
| 2026-05-12 | 38.00% | 82.96% | $0.30 | $59.48 |
| 2026-05-11 | 37.52% | 82.63% | $0.30 | $58.37 |
| 2026-05-10 | 37.52% | 82.63% | $0.30 | $58.60 |
| 2026-05-07 | 37.52% | 82.63% | $0.30 | $56.93 |
| 2026-05-06 | 37.52% | 82.63% | $0.30 | $58.23 |
| 2026-05-05 | 37.52% | 82.63% | $0.30 | $56.74 |
| 2026-05-04 | 37.52% | 82.63% | $0.30 | $57.62 |
| 2026-05-03 | 37.52% | 82.63% | $0.30 | $55.27 |
| 2026-04-30 | 36.50% | 81.36% | $0.29 | $53.78 |
| 2026-04-29 | 36.50% | 81.36% | $0.29 | $52.99 |
| 2026-04-28 | 38.67% | 78.83% | $0.28 | $53.85 |
| 2026-04-27 | 36.78% | 60.83% | $0.20 | $43.61 |
| 2026-04-26 | 33.87% | 64.28% | $0.21 | $42.79 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Kiniksa Pharmaceuticals International Plc's next-year EPS growth estimate?▾
As of 2026-06-04, Kiniksa Pharmaceuticals International Plc (KNSA) has a next-year EPS growth estimate of 39.55%, based on analyst consensus.
When was the latest EPS estimate revision for KNSA?▾
The most recent revision occurred on 2026-06-04, when analysts adjusted the next-year EPS growth estimate from 38.00% to 39.55%.
What sector and industry does Kiniksa Pharmaceuticals International Plc belong to?▾
Kiniksa Pharmaceuticals International Plc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. KNSA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Kiniksa Pharmaceuticals International Plc (KNSA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports